Ascensia Diabetes Care announced earlier this month that it has entered into a global alliance with Zhejiang POCTech, Co., Ltd, a Chinese company that makes continuous glucose monitoring (CGM) systems.
Ascensia will be the exclusive distributor for POCTech in an initial 13 specifically selected markets.
As part of this agreement, Ascensia will commercialize a version of POCTech’s current CGM product, the CT-100, in these areas and is intending to begin distributing the product in the second half of 2019.
CT-100 has the following features:
- Flexible and comfortable sensor
- Innovative four-electrode system
- Adjustable sensor implant angle
- A unique parallel sensor position
- Superb in-vivo stability
Ascensia and POCTech will also co-develop next-generation products that build on POCTech’s existing technology.
This agreement will leverage expertise from both companies to build and manufacture exciting next-generation products with enhanced capabilities and features that are designed to more effectively meet the needs of people with diabetes.
“We are committed to expanding our business beyond blood glucose monitoring and we see continuous glucose monitoring as a critical component of diabetes care,” said Michael Kloss, CEO, Ascensia Diabetes Care in a statement. “This partnership will enable us to bring an approved CGM product to selected markets in 2019 and at the same time create novel CGM systems that build on POCTech’s existing technology to address some of the unmet needs of people with diabetes.”
The agreement with POCTech is the key first step in building a world-class CGM franchise for Ascensia, according to Kloss. “We are aiming to use a combination of partnerships and our own in-house CGM development program to build a pipeline of state-of-the-art CGM products that improve on what is currently available for people with diabetes,” he adds.
Ascensia’s extensive R&D experience has led to the introduction of many user-centered innovations in diabetes, such as No-Coding technology and Second Chance sampling.
Ascensia is responsible for the development of the remarkably accurate CONTOUR NEXT test strip platform and hopes to apply their expertise in sensor development to the next generation of CGM systems through this collaboration.
1. Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems. (2019, Jan. 24), PR Newswire. Retrieved: https://www.prnewswire.com/in/news-releases/ascensia-diabetes-care-announces-global-partnership-with-poctech-to-distribute-and-co-develop-continuous-glucose-monitoring-systems-869723771.html